George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu Str., Targu Mures 540139, Romania.
Technical University of Cluj-Napoca, 28 Memorandumului Str., Cluj-Napoca-Napoca, 400114, Romania.
J Biol Phys. 2024 Dec;50(3-4):255-269. doi: 10.1007/s10867-024-09658-2. Epub 2024 Jun 27.
Bone is a complex tissue that fulfills the role of a resistance structure. This quality is most commonly assessed by bone densitometry, but bone strength may not only be related to bone mineral density but also to the preservation of bone cytoarchitectonics. The study included two groups of rats, ovariectomized and non-ovariectomized. Each group was divided into three batches: control, simvastatin-treated, and fenofibrate-treated. In the ovariectomized group, hypolipidemic treatment was instituted at 12 weeks post ovariectomy. One rat from each of the 6 batches was sacrificed 8 weeks after the start of treatment in the group. The experimental study was performed using a Bruker Minispec mq 20 spectrometer operating at a frequency of 20 MHz, subsequently also performed by H T-T molecular exchange maps. The results were represented by T-T molecular exchange maps that showed, comparatively, both pore size and their interconnectivity at the level of the femoral epiphysis, being able to evaluate both the effect of estrogen on bone tissue biology and the effect of the lipid-lowering medication, simvastatin, and fenofibrate, in both the presence and absence of estrogen. T-T molecular exchange maps showed that the absence of estrogen results in an increase in bone tissue pore size and interconnectivity. In the presence of estrogen, lipid-lowering medication, both simvastatin and fenofibrate alter bone tissue cytoarchitectonics by reducing pore interconnectivity. In the absence of estrogen, fenofibrate improves bone tissue cytoarchitectonics, the T-T molecular exchange map being similar to that of non-osteoporotic bone tissue.
骨是一种复杂的组织,起到抵抗结构的作用。这种特性通常通过骨密度测定来评估,但骨强度不仅可能与骨矿物质密度有关,还可能与骨细胞结构的保存有关。本研究包括两组大鼠,去卵巢组和非去卵巢组。每组又分为三组:对照组、辛伐他汀治疗组和非诺贝特治疗组。在去卵巢组中,在去卵巢后 12 周开始进行降脂治疗。每组的 6 个批次中的每批都有一只大鼠在治疗开始后 8 周被处死。该实验研究使用 Bruker Minispec mq 20 光谱仪在 20 MHz 的频率下进行,随后还进行了 HT-T 分子交换图谱分析。结果以 T-T 分子交换图谱表示,这些图谱比较了股骨骨骺水平的孔径大小及其连通性,能够评估雌激素对骨组织生物学的影响,以及降脂药物辛伐他汀和非诺贝特在存在和不存在雌激素的情况下的作用。T-T 分子交换图谱显示,雌激素缺乏会导致骨组织孔径和连通性增加。在存在雌激素的情况下,降脂药物辛伐他汀和非诺贝特都会通过减少孔径连通性来改变骨组织细胞结构。在缺乏雌激素的情况下,非诺贝特可改善骨组织细胞结构,T-T 分子交换图谱类似于非骨质疏松性骨组织。